SPRY2 and Hyperglycemia: In a recent study utilising whole-genome RNAi [16], SPRY2 was identified as a novel regulator of insulin transcription, and deletion of SPRY2 in adult mouse β-cells led to mild hyperglycaemia and hypoinsulinaemia.